John Hollister

John Hollister is a seasoned professional in the biotechnology and medical imaging sectors, currently serving as the Director of Marketing and Sales at Pressure BioSciences, Inc. since September 2019, focusing on the commercialization of UltraShear Technology™. Previously, John held the positions of CEO and Chairman at Imaging3, Inc., where significant advancements in 3D medical imaging technology were made. With a wealth of experience as a CEO across various companies such as NuLife Sciences and NEMUS Bioscience, John has demonstrated expertise in pharmaceutical development, capital raising, and strategic recruitment. Additionally, leadership roles at Tethys Bioscience and EEG Spectrum International showcase John's breadth of knowledge in marketing and management within the biopharmaceutical and neurofeedback fields. Academic credentials include an MBA from the Drucker School of Management and an AB in Economics from Stanford University.